Umesh Kunte

Umesh Kunte serves as Managing Director & CEO at Albert David Limited - India. Albert David Limited - India operates in the pharmaceuticals sector with approximately 630.0 employees. The company is headquartered in Mumbai, Maharashtra. Albert David Limited - India generates annual revenue of 10000000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 1,982 executive contacts are available in Maharashtra.
• • Our database includes 201,465 c suite-level executives.

Nginx Mobile Friendly AI

pharmaceutical manufacturing pharmaceutical formulations infusion solutions herbal dosage forms bulk drugs disposable syringes needles amino acids anti microbial haemostat anti-leishmaniasis lvp neurotropic vitamins placenta extract oral amino acids oral anthelmintics anti ulcerants anti vertigo appetite stimulants anti tubercular expectorants haematinics hepato protective laxatives nsaids systemic alkaliser uricosurics probiotics vitamin d3 topical agents vision care anti-glaucoma anti infective iso 9001:2008 certification gmp approved research & development innovative techniques sodium stibogluconate placentrex wound healing tissue regeneration biochemical characterization drug development quality assurance good manufacturing practices export registration clinical research regulatory compliance laboratory testing pharmaceutical exports pharmaceuticals medical

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Umesh Kunte in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Albert David Limited - India.

Umesh Kunte's Position in the MessageCEO Database

• •Umesh Kunte is 1 of 1 verified executive contact we track at Albert David Limited - India.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •1,979 verified executive contacts in Maharashtra are in the database.
• •6 verified contacts work at pharmaceuticals companies in the 630.0 employee range (same size as Albert David Limited - India).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Umesh Kunte directly?

Umesh Kunte's verified email address is available to MessageCEO Pro subscribers. They currently serve as Managing Director & CEO at Albert David Limited - India. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Umesh Kunte work for?

Umesh Kunte is Managing Director & CEO at Albert David Limited - India, a company in the pharmaceuticals sector with 630.0 employees. The company is based in Mumbai, Maharashtra.

Can I pitch or sell to Umesh Kunte?

As Managing Director & CEO at Albert David Limited - India, Umesh Kunte is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Umesh Kunte directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Umesh Kunte in?

Umesh Kunte works in the pharmaceuticals industry as Managing Director & CEO at Albert David Limited - India. MessageCEO provides verified contact information for executives across all major industries.

Is Umesh Kunte's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Umesh Kunte's profile is kept up-to-date with the latest available information.

Last updated: October 10, 2026